Progress Update on SJP-002C: Advancing Towards a Breakthrough in Anti-Inflammatory Therapy for Upper Respiratory Infections, including COVID-19 | Sen-Jam Pharmaceutical

https://wefunder.com/feed/171811

Published at: 2024-03-21 17:16:44 UTC

Author: Jim Iversen

Subject: Sen-Jam Pharmaceutical

Investors, Colleagues, and Friends, We have an update regarding our SJP-002C asset and are excited to share it with you. Frankly Speaking – SJP-002C Update Our Phase 2 clinical trial for SJP-002C, aimed at treating upper respiratory infections inc...